Company Analysis

SiNtx Technologies, Inc. SINT

A comprehensive view of key metrics, scores, and financial health for SiNtx Technologies, Inc.

Overview of Sintx Technologies, Inc.

SINT NCM

Healthcare Medical Devices Framework: Medical Devices & Diagnostics Micro Cap

Sintx Technologies, Inc. (SINT), is a Micro Cap company, in the Medical Devices industry, last closed at $1.71, about 0.0% overvalued vs fair value, -49.6% 1Y return, ranked 652/1145 in sector.

Metrics Rev Growth -41.5% ROE -303.8% Gross Margin 23.6%

USD 1.71

0.59%

(Delayed)

• Vol 90d: 68.0%

52-Week Range

Low

1.40

11%

Now 1.71

High

4.26

Market Cap

$11.40M

Enterprise Value

$7.91M

Overall Score

View breakdown

Overall

Growth

Fair

Profitability

Weak

Health

Fair

Efficiency

Fair

Valuation

Fair

Growth

Fair

Profitability

Weak

Health

Fair

Efficiency

Fair

Valuation

Fair

Completeness: 82%

Confidence: 86%

Updated: Oct 31

Top Beats

No strong beats yet

Quick Facts

Website https://www.sintx.com

HQ Salt Lake City, UT

Employees 20

Fiscal year Dec 31

Next Events

No upcoming events available.

Fair Value Snapshot

Bear Base Bull

$-2

Current: $1.71

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps

Total Revenue

$729.0K

-41.5%%

Gross Profit

$172.0K

-60.5%%

Operating Income (GAAP)

-$10.7M

23.7%%

EBITDA

-$9.7M

-0.4%%

Money Flow Bridge

You are currently seeing a limited view of the money flow waterfall.

See the full waterfall with all stages on Premium. Upgrade

Flow Direction: Money moves from left to right

Components: Breakdown shows composition of each stage

Industry-Specific: Medical Devices & Diagnostics

Data Quality Notes

Operating income is the as-reported (GAAP) figure, the same basis as net income.
Note: 'FCF Conversion' (FCF / Net Income) often exceeds 100% for MedTech companies. This is expected and desirable — M&A intangible amortisation depresses GAAP net income without consuming cash, making FCF the truer owner earnings proxy.
D&A is 90.8% of revenue — elevated, typically reflecting large M&A intangible amortisation. EBITDA margin is a more meaningful operating comparison across peers than GAAP operating margin.
Gross margin of 23.6% is below the typical MedTech benchmark (>65%). This may reflect a higher mix of hospital supplies, distribution revenue, or commodity-like product lines vs. proprietary IP-protected devices.

Quality & Reliability Indicators

Gross Margin

23.6%

Poor

Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$133.0K

Where It Leaks

Cash Flow Health critical

Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.

Active Leaks

1/1

Improving

High Impact

Critical

Interest Drag

Current: -198.3x

Allocation Leak

Improving

Scores based on quantitative metrics and qualitative factors

Full moat analysis

Key risks

Below-Peer Gross Margins Gross margin quality lags peers (score 0.15). May indicate commodity-like product mix or distributor margin drag.
Weak Capital Return Profile Capital return quality is below peers (score 0.07). Low ROIC raises questions about M&A discipline and pipeline ROI.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 83% Coverage

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked

Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

38th percentile vs peers

Key Signals

EPS Growth YoY 58.4% 69p Revenue CAGR 3Y 6.7% 50p Asset Growth YoY 1.0% 51p Rev Growth YoY -41.5% 8p

Strengths

No notable strengths identified for this axis.

Risks

Rev Growth YoY in bottom 20% of peers (-41.5%)

Profitability

10th percentile vs peers

Key Signals

Strengths

Risks

Premium

Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

17th percentile vs peers

Key Signals

Strengths

Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for SiNtx Technologies, Inc..

WACC X.X%

X%XX%

Rev CAGR 5Y X.X%

-XX%XX%

Op Margin XX.X%

-XX%XX%

Adjust the sliders above to explore different valuation scenarios.

Unlock Premium

Reveal the full Scenario Theatre

See live sliders, narratives, and full Bear/Base/Bull outcomes.

Upgrade Now

Bear

- - -

- upside

Base

$-2.16

- - -

- upside

Snapshot base estimate

Bull

- - -

- upside

Fair Value Range Current: $-

$- $- $-

SiNtx Technologies, Inc. SINT

Overview of Sintx Technologies, Inc.

Quick Facts

Next Events

Fair Value Snapshot

Engine Room Money Flow™

Flow Steps

Money Flow Bridge

Data Quality Notes

Quality & Reliability Indicators

Gross Margin

Locked Metric

Locked Metric

Locked Metric

Locked Metric

Locked Metric

Locked Metric

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Where It Leaks

Interest Drag

Key Metrics

Competitive Advantage Assessment

Key risks

Unlock full defense analysis

Pricing Power & Consumable Moat

R&D Pipeline & Capital Returns

FCF Quality & Cash Conversion

Commercial Execution

Capital Structure & Resilience

Growth Durability

Trade-Off Ledger™

Growth

Profitability

Safety

Two Futures

Actions & Info

Send Feedback